CMPX ▲ +1.6% - Compass Therapeutics, Inc. $CMPX d/g Neutral @ Wedbush pt 1 Compass Therapeutics rose 1.6% today following a Wedbush downgrade to Neutral with a $1 price target, suggesting the analyst sees limited upside from current levels. 23-SEP-2026 05:33 AM ET